CCL21 and cancer: Indeed, despite an upregulation of CCR7 even higher than gold standard DC, alternative DC displayed a reduced migration in vitro toward its ligand CCL21 and would then have poor migration to the lymph node upon subcutaneous or intradermal injection into cancer patients.